7 June 1990
COMMERCIAL ITEM DESCRIPTION
ERYTHROMYCIN TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-E-37256 which is cancelled.
Shall be Erythromycin Tablets, USP.
Shall be in accordance with the requirements of the USP. In addition, tablets shall have been approved by the FDA as therapeutically effective for administration to patients in both the fasting and non-fasting state.
Shall contain 250 mg of Erythromycin per tablet, within the applicable assay limits.
All ingredients shall be of pharmaceutical grade.
For Type I, shall be film-coated Erythromycin Tablets, USP.
For Type II, shall be enteric-coated Erythromycin Tablets, USP.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business